Salvatore Provenzano Selected Research

Epithelioid Hemangioendothelioma

1/2016

Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salvatore Provenzano Research Topics

Disease

15	Neoplasms (Cancer) 10/2022 - 12/2010
7	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 02/2013
4	COVID-19 01/2024 - 07/2020
4	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2016
2	Chordoma 01/2022 - 07/2016
2	Aggressive Fibromatosis (Desmoid) 01/2021 - 01/2020
2	Perivascular Epithelioid Cell Neoplasms 01/2019 - 01/2018
2	Chondrosarcoma 07/2016 - 01/2015
1	Pain (Aches) 06/2022
1	Lymphoma (Lymphomas) 12/2021
1	Fibroma (Fibromatosis) 01/2021
1	Leiomyosarcoma 01/2018
1	Mucositis 01/2018
1	Rare Diseases (Rare Disease) 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Smooth Muscle Tumor 01/2018
1	Alveolar Soft Part Sarcoma 01/2018
1	Myxoid Liposarcoma 01/2017
1	Hemangiopericytoma 07/2016
1	Pleural Effusion (Pleural Effusions) 01/2016
1	Epithelioid Hemangioendothelioma 01/2016
1	Hemangioendothelioma 01/2016
1	Bone Neoplasms (Bone Cancer) 01/2015
1	Febrile Neutropenia 02/2013
1	Neutropenia 02/2013
1	Chemotherapy-Induced Febrile Neutropenia 02/2013
1	Carcinoma (Carcinomatosis) 12/2010
1	Hyperplasia 12/2010
1	Inflammation (Inflammations) 12/2010

Drug/Important Bio-Agent (IBA)

5	Ifosfamide FDA LinkGeneric 01/2017 - 02/2013
2	Oxygen (Dioxygen)IBA 01/2024 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2010
2	Sirolimus (Rapamycin)FDA Link 01/2018 - 01/2016
2	Epirubicin (Ellence)FDA LinkGeneric 01/2017 - 02/2013
2	AnthracyclinesIBA 01/2017 - 01/2015
1	COVID-19 VaccinesIBA 01/2024
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	Brachyury protein (Brachyury)IBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	mRNA VaccinesIBA 01/2022
1	Vinca AlkaloidsIBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	AlkaloidsIBA 01/2020
1	MTOR InhibitorsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	pazopanib FDA Link 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	TrabectedinIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Melphalan (Alkeran)FDA LinkGeneric 01/2017
1	Gemcitabine FDA Link 01/2015
1	PlatinumIBA 01/2015
1	Etoposide (VP 16)FDA LinkGeneric 01/2015
1	LenograstimIBA 02/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2013
1	Proteins (Proteins, Gene)FDA Link 12/2010
1	Protein Isoforms (Isoforms)IBA 12/2010
1	EnzymesIBA 12/2010

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2024 - 02/2013
7	Therapeutics 01/2024 - 07/2016
2	Radiotherapy 06/2022 - 01/2016
1	Hyperthermic Intraperitoneal Chemotherapy 01/2023
1	Palliative Care (Palliative Therapy) 10/2022
1	Surgical Amputation (Amputations) 01/2022
1	Immunotherapy 01/2022
1	Operative Surgical Procedures 02/2021